Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
955.8 INR | +1.48% |
|
+0.93% | +47.22% |
May. 23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
May. 22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.22% | 1.04B | |
+21.80% | 43.81B | |
+30.40% | 23.03B | |
+21.32% | 15.45B | |
+19.05% | 14.4B | |
+58.92% | 12.95B | |
-0.05% | 6.79B | |
-11.84% | 6.49B | |
-8.87% | 5.73B | |
+13.00% | 5.49B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Acquires Minority Stake in Two Renewable Energy Companies